Purpose Chemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. We aimed to examine whether live or pre-recorded music listening decreases anxiety during chemotherapy in newly diagnosed lymphoma patients. Methods A total of 143 patients with non-Hodgkin and Hodgkin lymphomas were randomly assigned into three groups receiving either 30 min of patient-preferred live music (n = 47), 30 min of patient-preferred pre-recorded music (n = 47), or standard care (n = 49) during up to five outpatient chemotherapy sessions. The primary endpoint was anxiety measured by the Spielberger's State Anxiety Inventory. Secondary endpoints included blood pressure, pulse rate, nausea and vomiting, serum catecholamine levels pre-and post-intervention to measure arousal levels, and health-related quality of life. The Musical Ability Test was used to link musical ability to the primary endpoint. Results When adjusting for age, sex, diagnosis, number of sessions, and baseline anxiety, the linear mixed model showed a borderline statistically significant reduction in the primary outcome anxiety in the live music group compared to standard care (7% (95% CI, − 14% to 0%, p = 0.05), while the effect of pre-recorded music was non-significant (5% (95% CI, − 12% to + 3%, p = 0.18). No intervention effects were seen in secondary outcomes. Conclusion Our findings suggest that patient-preferred live music reduces anxiety among patients with malignant lymphomas undergoing chemotherapy. Musical ability among this group of cancer patients seems not to be a determining factor for effect of music intervention.
Background
Lymphoma patients undergoing chemotherapy may experience severe somatic and psychological side effects both during and after treatment [1] [2] [3] [4] . The main psychological side effect is anxiety arising from paralyzing and fearful thoughts when informed of the cancer diagnosis and concerns about prognosis, somatic effects of the cancer, and side effects of the toxic chemotherapy [5] [6] [7] . In the search for ways of intervening towards anxiety, music has been suggested to relieve this problem [8] [9] [10] [11] [12] [13] [14] .
In a recently published review and meta-analysis [14] , we found that six out of nine randomized controlled trials (RCTs) [15] [16] [17] [18] [19] [20] [21] [22] [23] showed significantly improved effects when offering live (3/6) or pre-recorded (3/6) music and active participation (3/6) or passive listening (3/6) to patients during chemotherapy compared to controls, both when anxiety was measured by the Spielberger State Anxiety Inventory Scale (STAI) [16] [17] [18] [19] [20] [21] [22] 24] and the Visual Analog Scale (VAS) [19, 25] . However, sample sizes were small, heterogeneity in diagnoses, type of given treatments, and stages of disease were large, and information on the patient's musical background, ability, and preferences lacked across studies [8, 14] . Further, to our knowledge, no RCT has investigated the effectiveness of live vs. pre-recorded music during chemotherapy compared standard treatment [14] . What are the musical needs of the patients? Is it either the musician's flexibility to adjust the tempo, repertoire and compliment the non-verbal moment-to-moment needs of the patient or a recorded musical experience to enhance inner dialog and relaxation? Although Bailey LM 1983 found significant effects on tension-anxiety, vigor, mood, and physical comfort of 25 min of live music compared to taped guitar/ voice music of the same material among 50 hospitalized cancer patients, lack of a control group, different treatments, and length of hospitalization do not provide basis for firm conclusions [26] . Music is related to activity in the brain's reward system, where it may induce emotions, moderate patients' mood, and thereby decrease pain and anxiety levels [27] [28] [29] . Further, neurological research has shown that musical background and competence are linked to the brain's processing of music [30] . Especially, patient-preferred music has the potential to regulate arousal levels, to evoke cognitive, emotional, and physiological responses and to create pleasure, distraction, and well-being [30, 31] . However, musical preference is only one aspect of music listening. To decrease emotional arousal, universal and cultural considerations are important to take into account, e.g., a slow tempo (60-80 beats per minute), volume, predictability in genre, rhythm, sound, musical structure, syntax, tonality, and instrumentation [27, 30] .
The objective of this randomized controlled study was to evaluate the effectiveness of patient-preferred live music or CD music to lower anxiety among patients with lymphomas undergoing first-line chemotherapy taking the qualities and features of musical stimuli, musical background, preference, and musical ability into account.
Methods

Design
We conducted a multi-center, randomized, and controlled trial in newly diagnosed patients with Non-Hodgkin and Hodgkin lymphomas undergoing ambulatory chemotherapy at six hospital departments of hematology in Denmark. We used a three-armed design with two interventional arms consisting of either 30 min of patient-preferred live music listening or patient-preferred pre-recorded music listening vs. standard care without music during chemotherapy.
Ethics
Approval was obtained from the The Regional Committees on Health Research Ethics for Southern Denmark (File no. S-20120118) (Komite.regionsyddanmark.dk). The study was reported to The Danish Data Protection Agency (File no. 2008-58-0035) (Datatilsynet.dk) and registered at ClinicalTrials.Gov (NCT01870479) (ClinicalTrials.gov).
Participants
The eligible patients were newly diagnosed with malignant lymphoma (Hodgkin or non-Hodgkin lymphoma), aged 18 or more, with planned ambulatory first-line intra-venous chemotherapy given intermittently every 2 to 3 weeks as 1-day administration. Non-Hodgkin lymphoma patients had most commonly diffuse, large B cell lymphoma, and more rarely follicular lymphoma or marginal zone lymphoma. Typical treatment regimens were CHOP (Cyclophosphamide, Hydroxydaunorubicin, Oncovin (Vincristine), Prednisolone), CVP (Cyclophosphamide, Vincristine, Prednisolone), or ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), given every 2-3 weeks. To participate in the study, patients should have at least three chemotherapy sessions planned. We excluded patients with mental illness, deafness, or blindness.
Obtaining informed consent and randomization
At the end of the first chemotherapy, a research nurse informed eligible candidates about the study and participant information was handed over. Patients who responded positively received further oral information and written informed consent was obtained by either the research nurse or the PI. Randomization was made by calling an independent research unit, who had a computer-generated randomization list. The included patients were stratified by type of lymphoma [Hodgkin and Non-Hodgkin lymphoma], sex, and age [Hodgkin, ± 35 years; nonHodgkin, ± 50 years] using the software program R.
Power calculation and statistical analysis
Power calculation was based on a two-sided ANOVA test [32] on the mean reduction in the primary outcome anxiety measured by STAI-YI score in the three treatment groups. Assuming a within group variation similar to the between group variation, MIREDIF of 10%, significance level of 5%, and power of 90%, the number of participants needed was calculated to 25 in each group. Taking into account a maximal dropout rate of 30%, a total of 105 patients were planned to be included in the study. The initial dropout rate was higher than expected, and in an amendment we therefore increased the number of participants to 143 patients.
The patient characteristics at baseline were summarized by the intervention group as mean and SD for continuous variables and n (%) for categorical variables. The primary outcome was the level of anxiety as measured by the STAI-Y1 scale. A linear mixed model for all visits (baseline to chemo 6) was applied where the three intervention groups were assumed to be the same at baseline (as they were randomized) and after baseline different intervention effects at each visit were allowed. The observations from each individual were assumed to be correlated and this was considered using an unstructured covariance matrix. If possible, the model was simplified by testing for the same intervention effect at each visit.
The analyses were adjusted for the baseline factors sex, age group (± 50), and lymphoma subtype (non-Hodgkin, Hodgkin). Assumptions underlying the model were checked using residual plots in case the data needed to be transformed (e.g., using a logarithm). The same analysis strategy was also used for the continuous secondary outcomes.
Missing values were assumed to be "missing at random" as we assumed that the missing observations did not depend on the unobserved outcomes.
In order to measure the intervention effect size on primary outcome of the live music group vs. control and the CD group vs. control, Cohen's d was obtained by dividing the mean difference scores by the control group baseline standard deviation (SD = 0.41 on the log-scale).
Intervention
Group I (live music) Based on the patients oral and written feedback on musical preference, musical background, wishes for specific music pieces/genres, and constellation of musicians (see Appendix 1), the PI chose musicians for the first treatment. Subsequently, one to three musician(s) planned a suitable repertoire, and the sound level was considered. The planned chemotherapy and music intervention took place in a multi-bed room where participants in the control group and intervention group 2 could not hear the music. All preparations, venous puncture, oral information regarding the treatment, anti-emetic medication, were completed before the music started. The intervention itself consisted of the patient's favorite music genre, special pieces of music/songs (25-30 min) with an average tempo of 60-80 beats per minute. In order to make the two intervention groups comparable, the musicians and the patients were informed to limit the communication during the intervention. Numbers of planned treatments varied between patients; thus, the musicians played from the second and up to the third to sixth chemotherapy sessions Any request for a new repertoire and constellations of musicians was agreed between the PI and the patient immediately after or between each of the up to five music sessions.
Musicians
Twenty-one musical groups from the Danish National Academy of Music [33] participated; classical guitar solo/duo, classical singing/piano, classical piano soloist, classical violin/ guitar, pop/rock singer/guitar, blues guitar/bas, pop/rock/folk singing/piano/contrabass, jazz trio. To ensure the intervention quality in group I, the musicians had attended SDMK's [33] hospital project for at least 2 years. Thus, they had passed a 4-h introductory course dealing with patient information, communication, music psychology, differentiated music communication, and choice of repertoire and they had played at least 10 concerts at the ward in conjunction with supervision by PI on performance skills and choice of suitable repertoire. The PI informed all musicians about the project and a "musician guideline" was handed over, followed by confidentiality signatures required by hospital departments involved.
Group II (CD music)
The same oral and written feedback from the patients as in group I was used to plan the music interventions in group II, and any request for new repertoire was agreed between the PI and the patient immediately after or between each of the up to five music sessions. The patients brought their favorite music or the PI produced CDs through ITunes for those who did not have the opportunity to do so. The CDs were created from the same considerations regarding musical preference and tempo as in intervention group 1. The music was played on a music center (Denon DCD-720AE CD Player) with headphones (Denon AH-D340 Headphones) for 25-30 min starting at the beginning of each chemotherapy treatment. The patients determined the volume. Care and human contact were the same as in group one and the control group, given by the staff at the department.
Group III (control)
The patients in the control group were not allowed to listen to music during planned chemotherapy.
All three groups received standard supportive care including anti-emetics according to national recommendations, which also include anti-pyretic and steroids in ABVDtreated patients. Chemotherapy treatments were given by the same staff and in similar rooms.
End of intervention assessment
Two to four weeks after completion of the last protocolled chemotherapy with music intervention or control visits, the patients were called by telephone for an interview. Hodgkin lymphoma patients received up to 16 chemotherapy courses and therefore the "end of music intervention assessment" was conducted before the seventh chemotherapy.
Measurements
Before randomization, all included participants completed the following validated questionnaires on outcome variables (STAI-YI [24] , EORTC-QOL-30 [34] , and GOLD-MSI [35] ).
At the second to the sixth chemotherapy treatment, the research nurse measured vital parameters (blood pressure, heart rate) immediately before and after each chemotherapy.
At the same treatment session a peripheral venous catheter was inserted at least 30 min before chemotherapy was started. Blood samples were collected immediately before start of chemotherapy and repeated 5 min after stopping. Samples were analyzed for plasma catecholamine's (epinephrine and norepinephrine) [36] .
The patients completed the self-administered questionnaires on anxiety (STAI-YI) immediately after each given chemotherapy and completed the health-related quality of life questionnaire (EORTC-QLQ-C30) [34] after the second, fourth, and sixth given chemotherapy. Furthermore, the patients filled out an in-house validated diary questionnaire for the assessment of nausea and vomiting between every chemotherapy treatment.
At the end of music intervention assessment, they filled out the questionnaires STAI-YI and EORTC-QOL-30. In addition, the patients performed the Musical Ear Test (MET) [37] .
Questionnaires
Primary outcome
We used STAI-YI to measure anxiety. The Spielberger StateTrait Anxiety Instrument (STAI-YI) is a self-reported questionnaire [24] . It consists of 20 items in a four-point Likert format ranging from 1 (not at all) to 4 (very much so). The STAI-YI form reveals the anxiety level right now. According to Barnason, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] points is considered as low anxiety, 40-59 points as moderate anxiety, and 60-80 points as high anxiety [38] .
Secondary outcome
The European Organization Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-30) [34] measured health-related quality of life.
Baseline measurements
We measured patients' musical competence and background by using the MET Test [37] and the Goldsmith Musical Sophistication Index [35] , respectively. The Musical Ear Test distinguishes between groups of non-musicians, amateurs, and professional musicians, and we used this test to form the basis for identifying whether the musical ability of the patients was important outcome measurements. The Goldsmith Musical Sophistication Index is a validated, selfreported inventory, and test battery for individual differences in musical sophistication [35] . Further, we added three questions regarding musical wishes, preferences, and hearing ability (see Appendix). Figure 1 shows the flowchart of the study. After exclusion of 34 (10%) of the 344 patients initially eligible for the study, we obtained informed consent from 143/310 (46%) consecutive patients. The main reason for eligible patients to decline inclusion was incapacity to oversee participation in the research project after the very recent cancer diagnosis. There were no imbalances between the three groups, when comparing baseline characteristics (Table 1) .
Results
Primary outcome
Baseline scores of anxiety were low across groups (live music, 33.4; recorded music, 35.6; controls, 33.1). When adjusting for age, sex, diagnosis, number of sessions, and baseline anxiety, we found a borderline significant decrease in anxiety in the live music group with a 7% reduction in STAI-YI from baseline (95% CI − 14 to 0%) compared to standard care (p = 0.05) ( Table 2 ). There was a non-significant decrease in anxiety when comparing the recorded music group with standard care (5% (95% CI, − 12 to 3%, p = 0.18) and no statistically significant difference between the two music intervention groups. When calculating the Cohen's d, we found a modest effect size in the live music group (d = 0.27), whereas no effect was found in the recorded music group (d = 0.18) compared to controls.
Secondary outcomes
There were no significant differences in secondary outcome measurements in either of the music intervention groups or when analyzing the overall effects of intervention (Table 3) .
Further, there were no statistically significant effects on nausea and vomiting observed in the patient diaries between groups. The number of patients with vomiting was very low, and at least 70% of the patients indicated no nausea on the different days. Reporting of nausea and vomiting was most frequent the first day after chemotherapy, and reported more in Hodgkin lymphoma patients than in non-Hodgkin lymphoma patients (not shown).
Data about the music provided
The music provided ranged from patient-preferred classical, jazz, folk, rock to pop music. Across the 397 music interventions live-and pre-recorded music combined, contemporary music, e.g., jazz, folk, rock, pop, was the most frequently performed music style (73%) compared to classical music (27%), with an average tempo on 71 beats per minute and a percentage distribution in vocal/instrumental music (61/ 39%) and major/minor key 79/21%, respectively. Out of 198 live music interventions, classical guitarists and pop/rock singers/guitarists played during 125 chemotherapy treatments. The three intervention groups were similar as regards to their general musical sophistication [35] and musical ability [37] ( Table 4) . When adding the total MET score to the model for change in STAI-YI, we found no evidence that the intervention worked better for participants with a high compared to those with a low musical ability (p = 0.79).
Discussion
In this large multi-center clinical trial, we showed that patientpreferred live music with an average tempo of 60-80 beats per minute had a borderline significant effect on anxiety among lymphoma patients undergoing two to five ambulatory chemotherapy sessions compared to controls. A significant decline in anxiety was not observed in the CD group compared to controls. To our knowledge, this is the first live music listening study suggesting that the degree of anxiety relief among lymphomas undergoing chemotherapy seems not determined by musical ability, hence a possibility for many cancer patients. Surprisingly, the baseline anxiety scores were low in our study, compared to three similar studies showing significant anxiety decrease measured by STAI, by offering recorded music during chemotherapy. These studies all reported moderate anxiety levels at baseline between 39 and 52 [16, 21, 22] . Due to optimizing inclusion rates, we, as the only study, included patients and collected baseline scores after the first chemotherapy, whereas for instance Li collected baseline scores on the day before radical mastectomy and offered music at discharge and during the following two ambulatory chemotherapy treatments [21] . Anxiety may diminish considerably after the first chemotherapy, and possible therefore we had limited ability to register anxiety decrease above 7% (floor and ceiling effect). We might have found larger effect of intervention if we had done the baseline measurements before the first chemotherapy or we might have pre-selected participants based on evidence of high levels of anxiety in order to target the intervention to those with high needs. When calculating Cohen's d effect size, live vs. control, we found a modest effect size [39] . Live music offers the flexibility for the musician(s) to personalize the music interventions. Rossetti points out that personalized and targeted music interventions should go hand in hand with personalized medicine [40] . However, awareness of the patient's role in the intervention is needed [14] . We conducted a passive listening approach in order to equalize groups by restricting the communication between the musician(s) and the patient.
It is noteworthy that patients in this study predominantly chose music in the major key. This differs from a "minor key"-trend in society, supported by The Billboard Magazine [41] , saying that today American pop hits consist of 44% major key and the tendency is downward. This indicates that optimistic tunes may be preferred during chemotherapy.
According to our recent review [14] , the complexity of conducting multiple session studies more often leads to nonsignificant results compared to single session design studies. Three multi-session RCT failed to reach significance on the primary outcome variable nausea [23] , anxiety [15] , and distress [18] applying passively listening (1/3) or active participation (2/3) during or after inpatient chemotherapy treatment. Delays in treatment, hospitalization, midway cancer status evaluation, and thus the risk of altering the prognosis, as well as disease and treatment-related problems, are frequent and give rise to a persistent and prolonged mental strain among the patients. On the contrary, single session designs often imply increased levels before procedure and immediate relief afterwards. This may be the reason why we did not see an effect of music intervention on quality of life (EORTC-QOL-30). Andrade et al. argue that quality of life is difficult to measure among hematology/oncology patients undergoing chemotherapy due to individuality and multidimensionality [1] . Music is a multi-faceted, cultural, and social phenomenon, difficult to simplify into measurable test parameters in the complexity of cancer treatment. Nevertheless, this study indicates that live music may provide some anxiety relief in a long-term course of chemotherapy treatment to lymphoma patients.
Clinical implications
Live music without any components from music therapy, performed by qualified, well-trained musicians in response to patient-preferred selections, genre, artist, and song, may be used for reduction of anxiety in patients with lymphomas undergoing chemotherapy; however, low levels of inclusion and baseline anxiety prevent firm conclusions and call for more multi-session studies targeting live music to the patient's phase of treatment and timing of intervention.
Strengths and limitations
It is a strength of our study that we included a welldescribed and uniform group of lymphoma patients receiving first-line chemotherapy in a sequential one-day treatment schedule. We managed to overcome running of a multi-center, multiple sessions study in very sick lymphoma patients and the logistic challenges among musicians with potential delays of treatment. Further, the Table 4 The patients' musical background, preferences, and ability measured by The Goldsmith Sophistication Index (GOLD-MSI) and The Musical Ear Test (MET) reported by Intervention Group guidelines for music-based interventions by Robb [42] were used to conduct the study, and the participants' musical backgrounds as well as musical abilities were obtained in order to adjust for these potential confounders.
However, some limitations must be noted. First, the number of given chemotherapy courses varied across lymphoma subtypes; Hodgkin lymphoma patients usually went through 12-16 treatments, whereas non-Hodgkin lymphoma patients received between 3 and 6 treatments. Due to this heterogeneity, the end of assessment visit happened at some time-point after the end of the cancer treatment and not after the same time interval for everybody. For that reason, end of assessment data was not included in the main analysis. Second, the different numbers of chemotherapy sessions and hereby also music interventions across groups might have influenced the results. The fact that only 14% of the patients in the CD group received less than five music interventions whereas this proportion was 27%, and thereby significantly higher, in the live music group might have weakened the effect of live music, and the linear mixed model analysis chosen for this study cannot take this imbalance into account. Finally, only 46% of the eligible patients were included in the study due to lack of mental and physical energy, and this will inevitable weaken the strengths of the results. Possibly, a pre-intervention assessment of the psychological needs might have ameliorated this problem.
Conclusion
We found a borderline significant decrease in anxiety by offering patient-preferred live music compared to standard care during first-line chemotherapy sessions in newly diagnosed lymphoma patients.
